SCHEMBL22723340

SCHEMBL22723340

Cc1cc2cnn(C3CCCCO3)c2cc1[C@H]1CCN(C(=O)OC(C)(C)C)C[C@H]1O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR119 Q8TDV5 3/20 0.40
▸ RXRA P19793 1/20 0.39
▸ RXRB P28702 1/20 0.39
▸ RXRG P48443 1/20 0.39
▸ ALK Q9UM73 2/20 0.39
▸ CCNK O75909 1/20 0.38
▸ CDK12 Q9NYV4 1/20 0.38
▸ KRAS P01116 1/20 0.36
▸ CDK4 P11802 1/20 0.36
▸ CCND1 P24385 1/20 0.36
▸ CCND3 P30281 1/20 0.36
▸ CDK6 Q00534 1/20 0.36
▸ JAK2 O60674 1/20 0.36
▸ JAK3 P52333 1/20 0.36
▸ PTK2 Q05397 1/20 0.36
▸ MEN1 O00255 2/20 0.36
▸ KMT2A Q03164 2/20 0.36
▸ PDE4B Q07343 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ TP53 P04637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20437475 1.00 GPR119 (0.40) GPR119RXRARXRBRXRGALK
SCHEMBL21796615 1.00 GPR119 (0.40) GPR119RXRARXRBRXRGALK
SCHEMBL21797025 0.93 RXRA (0.40) GPR119RXRARXRBRXRGALK
SCHEMBL21797023 0.93 RXRA (0.40) GPR119RXRARXRBRXRGALK
SCHEMBL18399288 0.92 TRPV3 (0.41) GPR119RXRARXRBRXRGALK
SCHEMBL21796877 0.92 TRPV3 (0.41) GPR119RXRARXRBRXRGALK
SCHEMBL28608598 0.92 TRPV3 (0.41) GPR119RXRARXRBRXRGALK
SCHEMBL18398983 0.91 LRRK2 (0.40) GPR119RXRARXRBRXRGCCNK
SCHEMBL31084354 0.91 GPR119 (0.39) GPR119RXRARXRBRXRGALK
SCHEMBL20437352 0.91 LRRK2 (0.40) GPR119RXRARXRBRXRGCCNK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10858367-B2 Compounds GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2020-12-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10858367-B2 Compounds LRRK2, PARK7, PINK1 GPR119 2271/4885RXRA 4584/4885RXRB 4530/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback